Literature DB >> 19049999

Fueling innovation in medical devices (and beyond): venture capital in health care.

D Clay Ackerly1, Ana M Valverde, Lawrence W Diener, Kristin L Dossary, Kevin A Schulman.   

Abstract

Innovation in health care requires new ideas and the capital to develop and commercialize those ideas into products or services. The necessary capital is often "venture capital," but the link between public policy and the venture capital industry has not been well examined. In this paper we explore the link between venture capital and innovation in health care, and we present new descriptive data from a survey of health care venture capital fund managers. Respondents generally viewed policy levers (for example, reimbursement and regulations) as important risks to venture capital investments, potentially affecting their ability to raise capital for early-stage investment funds.

Mesh:

Year:  2008        PMID: 19049999     DOI: 10.1377/hlthaff.28.1.w68

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  8 in total

1.  A policy approach to the development of molecular diagnostic tests.

Authors:  Kevin A Schulman; Sean R Tunis
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

2.  Endovascular repair of aortic disease: a venture capital perspective.

Authors:  Lucas W Buchanan; S William Stavropoulos; Joshua B Resnick; Jeffrey Solomon
Journal:  Semin Intervent Radiol       Date:  2009-03       Impact factor: 1.513

3.  Types and Distribution of Payments From Industry to Physicians in 2015.

Authors:  Kathryn R Tringale; Deborah Marshall; Tim K Mackey; Michael Connor; James D Murphy; Jona A Hattangadi-Gluth
Journal:  JAMA       Date:  2017-05-02       Impact factor: 56.272

4.  Venture funding for science-based African health innovation.

Authors:  Hassan Masum; Justin Chakma; Ken Simiyu; Wesley Ronoh; Abdallah S Daar; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

5.  Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa.

Authors:  Hassan Masum; Peter A Singer
Journal:  BMC Int Health Hum Rights       Date:  2010-12-13

6.  Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovation.

Authors:  Aaron S Kesselheim; Shuai Xu; Jerry Avorn
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

7.  How does venture capital operate in medical innovation?

Authors:  P Lehoux; F A Miller; G Daudelin
Journal:  BMJ Innov       Date:  2016-04-15

8.  Health systems as venture capital investors in digital health: 2011-2019.

Authors:  Kyan C Safavi; Adam B Cohen; David Y Ting; Sreekanth Chaguturu; Jack S Rowe
Journal:  NPJ Digit Med       Date:  2020-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.